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HipA is a bacterial serine/threonine protein kinase
that phosphorylates targets, bringing about persis-
tence and multidrug tolerance. Autophosphorylation
of residue Ser150 is a critical regulatory mechanism
of HipA function. Intriguingly, Ser150 is not located
on the activation loop, as are other kinases; instead,
it is in the protein core, where it forms part of the ATP-
binding ‘‘P loop motif.’’ How this buried residue is
phosphorylated and regulates kinase activity is
unclear. Here, we report multiple structures that
reveal the P loop motif’s exhibition of a remarkable
‘‘in-out’’ conformational equilibrium, which allows
access to Ser150 and its intermolecular autophos-
phorylation. Phosphorylated Ser150 stabilizes the
‘‘out state,’’ which inactivates the kinase by disrupt-
ing the ATP-binding pocket. Thus, our data reveal
a mechanism of protein kinase regulation that is vital
for multidrug tolerance and persistence, as kinase
inactivation provides the critical first step in allowing
dormant cells to revert to the growth phenotype and
to reinfect the host.
INTRODUCTION
Bacterial persistence is largely responsible for the inability of
antibiotics to eliminate infections and is caused by a small
subpopulation of cells called persisters (Lewis, 2007, 2010).
Persisters are not mutants but phenotypic variants of wild-type
cells that escape antibiotic eradication by adopting a transient
dormant state (Lewis, 2007, 2010). Dormancy provides protec-
tion because antibiotics typically act by corrupting active targets
into producing toxic by-products. If the cells remain quiescent
until the drug is removed and then revert back to growth, multi-518 Cell Reports 2, 518–525, September 27, 2012 ª2012 The Authordrug tolerance (MDT) results. A critical component in the devel-
opment of MDT is the ability of persister cells to emerge from
dormancy and reestablish an active growth phase. How such
reversion occurs is unknown and represents an outstanding
question in the field. The recent discovery of persisters in bio-
films has highlighted the importance of understanding these
mechanisms as they play important roles in the etiology of recal-
citrant infectious diseases. An estimated 65%–90% of all infec-
tions are associated with biofilms (Laza˜r and Chifiriuc, 2010). The
phenomenon of MDT, however, has been extremely difficult to
study, as persisters comprise less than 1% of a typical bacterial
population (Lewis, 2007). In fact, although MDT was first
described in 1944 by Bigger, the first bona fide persistence
factor was only identified in 1983. This factor was called HipA,
for high persistence factor A (Bigger, 1944; Moyed and Bertrand,
1983; Moyed and Broderick, 1986).
HipA is a 50 kDa protein, which when mutated led to dramatic
increases in persistence in Escherichia coli (Moyed and
Bertrand, 1983; Moyed and Broderick, 1986; Black et al., 1991,
1994). Subsequently HipA has been shown to be present in
multiple Gram-negative bacteria for which genomic sequences
are available. In these bacteria, HipA is part of a chromosomally
encoded operon, hipBA, which also encodes the 10 kDa HipB
protein (Moyed and Bertrand, 1983; Moyed and Broderick,
1986). HipB is a DNA-binding protein that autoregulates tran-
scription of the hipBA operon. HipB also interacts with HipA
to disable its persistence function (Black et al., 1991, 1994).
Recent studies revealed that HipA adopts a eukaryotic serine/
threonine protein kinase fold and phosphorylates in vitro the
essential translation factor, EF-Tu, suggesting a mechanism
of cell stasis via inhibition of protein synthesis (Correia et al.,
2006; Evdokimov et al., 2009; Schumacher et al., 2009). The
HipA-HipB-DNA structure indicated that HipB neutralizes
HipA through conformational inactivation and sequestration
(Schumacher et al., 2009). Thus, HipA and HipB can be catego-
rized as a chromosomally encoded toxin-antitoxin (TA) module,
where HipA is the toxin and HipB is the antitoxin (Hayes ands
Figure 1. Extrusion of the P Loop Motif of Ser150-Phosphorylated
HipA
(A) Superimposition of HipA(D309Q) and pHipA. (Left) The structures are
shown as ribbons and colored gray except for their P loop motifs, which
are green in HipA(D309Q) andmagenta in pHipA. (Right) Only the P loopmotifs
are shown to underscore the dramatic conformational change resulting from
the ejection of the P loop motif from the protein core. Phosphorylated Ser150
(pS150) and Ser150 (S150) are shown as dotted spheres. Residues 134 and
155 are also labeled for reference. The P-loop motif is also ejected, but dis-
ordered, in the HipA(S150A) mutant structure (see Figure S1).
(B) Ribbon diagram of the HipA(D309Q)-ATP structure (PDB code 3DNU)
(Schumacher et al., 2009). The P loop motif is colored green and ATP is shown
as red sticks.
(C) Ribbon diagram of pHipA in the same orientation as Figure 1B highlighting
the separate N-subdomains (colored cyan and blue) and folded activation
region that are created by P loop motif ejection. pS150 is shown as dotted
yellow spheres.Van Melderen, 2011). However, neither HipA nor HipB shows
homology with any of the TA proteins in any system marking
them as a unique TA module.
In addition to its binding to HipB, HipA is regulated by auto-
phosphorylation on residue Ser150 (Correia et al., 2006).
Remarkably, the HipA structures reveals that Ser150 is buried
in the protein core (Schumacher et al., 2009). This is in sharp
contrast to the phosphorylated regulatory sites of other protein
kinases, which are typically located on solvent exposed loops.
Studies in which Ser150 was replaced by alanine resulted in
a loss of persistence, which led to the suggestion that Ser150Celphosphorylation is necessary for kinase activation and therefore
persistence (Correia et al., 2006). To gain insight into the seem-
ingly paradoxical questions of how a residue buried in the protein
hydrophobic core can be phosphorylated and how this phos-
phorylation affects HipA kinase activity, we carried out structural
and biochemical studies on this key persistence factor. The data
reveal a heretofore-unseen mechanism of kinase regulation and
suggest a molecular basis for how persister cells can emerge
from dormancy to cause reinfection.
RESULTS AND DISCUSSION
Structure Determination of pHipA and Comparison
with Nonphosphorylated HipA
To gain insight into how the buried Ser150 residue in HipA is
phosphorylated, we purified the wild-type (wt) phosphorylated
HipA protein (pHipA) and performed structural studies. Two
crystal structures (trigonal and monoclinic) of pHipA were
determined to 1.90 and 1.50 A˚ resolution, respectively, by
molecular replacement using the previously determined struc-
ture of HipA(D309Q), a catalytically inactive enzyme due to the
replacement of the catalytic base, residue Asp309, with a gluta-
mine (Jones et al., 1991; Bru¨nger et al., 1998; Schumacher et al.,
2009). The final Rwork/Rfree values for the structures were 18.4%/
24.3% and 21.2%/24.8%, respectively (Table S1).
Comparison of the pHipA and nonphosphorylated
HipA(D309Q) structures showed that while they are similar over-
all, the region of pHipA, which encompasses residues 134–155
and includes phosphorylated Ser150 (pS150), adopts a vastly
different conformation (Figures 1A–1C). In the HipA(D309Q)
structure, residues 134–155 are part of the hydrophobic core
of the N-domain. In the pHipA structures, these residues are
extruded by over 30 A˚ from their internal location into the solvent.
In the monoclinic pHipA structure, residues 143–155 are mostly
disordered while in the trigonal pHipA structure these residues
form a well-defined extended structure that lies over the active
site and interacts with the putative activation loop/region (resi-
dues 185–195), which is disordered in the HipA(D309Q) structure
(Schumacher et al., 2009). Two flexible regions consisting of resi-
dues 134–147 and 155–157 appear to provide the necessary
conformational malleability to permit loop extrusion (Figure 1A).
Also important for loop ejection is the paucity of contacts
between HipA residues 148–154 and other residues in the
protein core and a repositioning of helix a3.
Destruction of the HipACatalytic P LoopMotif by Ser150
Expulsion: The In and Out States
The finding that a portion of the protein core is ejected and
becomes solvent exposed in pHipA is striking, but more critical
is the finding that these expelled residues encompass a catalyti-
cally essential region, the so-called catalytic glycine-rich or P
loop motif (Huse and Kuriyan, 2002; Fernandez-Fuentes et al.,
2004; Taylor and Kornev, 2011). Typical protein kinase glycine-
rich motifs consist of an eight residue hairpin-like loop that is
located between two b strands. The tip of this b loop-b motif
(herein referred to as the P loop motif) encircles the ATP phos-
phates and is essential for catalysis. In HipA, the P loop motif
(151-VAGAQEKT-158) diverges from those found in otherl Reports 2, 518–525, September 27, 2012 ª2012 The Authors 519
Figure 2. The Phosphorylated P Loop Motif
Can Interact with and Occlude the HipA
Catalytic Pocket
(A) Ribbon diagram of the trigonal pHipA structure.
The P loop motif is colored yellow and residues
involved in mediating interactions between
N-subdomains 1 and 2 and between the P loop
motif and the protein are shown as sticks and
labeled. The catalytic base, residue Asp309
(D309), is labeled.
(B) View of the interactions nearby and involving
residue R78 in the out-state (pHipA, blue) and the
in-state (HipA[D309Q], salmon) conformations.
Also shown are contacts between Y79 and Y132
that help stabilize the ‘‘out-state’’ conformation.
(C) Overlay of the trigonal pHipA (blue) and
HipA(D309Q)-ATP (red) structures. The superim-
position shows that the phosphate group of pS150
overlaps the ATP g-phosphate (dotted spheres)
in this autoinhibited out-state conformation. Each
P loop is labeled and that belonging to pHipA is
colored yellow.
(D) Closeup of the overlapping ATP g-phosphate
and the pS150 phosphate group. The ATP and
phosphate group of pS150 are shown as sticks
and dotted surfaces and the P loop motifs of
pHipA (yellow) and HipA(D309Q)-ATP (red) are
labeled.
See also Figure S1.protein kinases as it contains only one glycine (Pereira
et al., 2011). As a result, it has a slightly altered conformation
when compared with typical serine/threonine kinase P loops.
Nonetheless, in the HipA(D309Q)-ATP structure this region
is used to embrace the ATP phosphate groups (Figure 1B).
What is particularly notable is that the structural change
observed in the pHipA structures leads to the complete
destruction of this essential catalytic loop conformation (Figures
1A and 1B).
Thus, the structural data on HipA indicate that the P loop motif
exists in equilibrium between two conformations, which we call
the ‘‘in state’’ and ‘‘out state.’’ We note that the out state is not
meant to indicate one specific conformation but rather any
conformation in which the P loopmotif is ejected from the hydro-
phobic core. Interestingly, the HipA N-terminal domain in which
the P loopmotif resides is larger than the corresponding domains
of most protein kinases. In HipA, the P loop motif forms the
central strand of the b sheet of the domain. Hence, ejection of
this region disrupts this b sheet of the N-domain and leads to
the creation of N-subdomains 1 and 2 (Figure 1C). N-subdomain
2 contains substrate-binding residues while the role of N-subdo-
main 1 is unknown, but mutations in residues in this subdomain
can result in a high persistence phenotype (Moyed and Bertrand,
1983; Korch et al., 2003; Korch and Hill, 2006; Lewis, 2007). The
cavity between the N-subdomains that results from P loop motif520 Cell Reports 2, 518–525, September 27, 2012 ª2012 The Authorsexpulsion is filled with solvent, which
now links the disjointed strands of the
N-domain b sheet.
Additional comparison of in-state and
out-state structures reveals different setsof contacts in each state and these interactions, which are nearly
equal in number, appear to be equally balanced. In the in state,
Arg78 forms multiple hydrogen bonds with the backbone
carbonyl oxygens of residuesMet140, Ile141, andGlu144. These
interactions buttress residues 140 through 147, allowing them to
form a distorted helix-loop structure (Figures 2A and 2B). In the
out state, Tyr132 and Arg78 rotate into the cavity vacated by
residues 140–147. From its new location, the side chain of
N-subdomain 2 residue Tyr132 makes a weak hydrogen bond
to N-subdomain 1 residue Tyr79 and residue Arg78 now inter-
acts with the side chain of Glu156, which is found on the tip of
the P loop motif of ATP-bound (in-state) HipA (Figures 2A and
2B). In order to form this latter contact, Glu156 adopts a
conformation that disfavors canonical P loop formation. Thus,
these contacts and the nonstandard P loop conformation aid in
the unraveling of the P loop motif. By contrast, in the ATP-bound
state, Glu156 interacts with Arg74 and this interaction favors the
ATP-binding conformation of the P loop motif. Consistent with
playing a key role in HipA function, Arg78 is conserved in all
HipA proteins.
The Phosphorylated HipA pS150 Loop Can Function
as an Intramolecular ‘‘Product’’ Autoinhibitor
In the trigonal pHipA structure, the P loop motif binds in the
active site and the phosphate of residue pSer150 overlaps
the position of the g-phosphate of ATP observed in the
HipA(D309Q)-ATP structure (Figures 2C and 2D). Moreover,
when bound in this manner, the pSer150 side chain interacts
directly with the side chain of the proposed catalytic base,
residue Asp309. The utilization of a loop, which mimics a bound
substrate, is a well-described mechanism to inhibit protein
kinases. These so-called ‘‘pseudosubstrates’’ can be provided
from regulatory subunits or loops within the kinase itself
(Cheetham, 2004). In the pHipA structure, the phosphorylated
Ser150 functions as a novel kind of intramolecular ‘‘pseudoprod-
uct’ inhibitor that not only comes from the protein itself but is
part of the active site. Interestingly, when the P loop motif binds
to the catalytic pocket, residues 134–155 of the P loop motif
interact with and permit folding of the normally disordered acti-
vation region (residues 185–195) into a b hairpin (Figure 1C).
Folding of the activation region of HipA has been observed previ-
ously only when an EF-Tu peptide substrate was bound
(Schumacher et al., 2009).
Structural Basis of HipA Inactivation by the S150A
Mutation
The ability of the P loopmotif of HipA to take an out-state confor-
mation provides an explanation for autophosphorylation of
residue Ser150 as expulsion of the P loop motif exposes this
residue to the solvent (Figure 1A). Once phosphorylated, the
large electronegative phosphate group precludes reinsertion of
the P loop motif into the core. However, previous data showing
that mutation of residue Ser150 to alanine (S150A) abolishes
the ability of HipA to mediate persistence led to the suggestion
that phosphorylation of Ser150 is required for kinase activation
(Correia et al., 2006). This appears contrary to our structural
data, which would predict that the phosphorylated out-state
conformation of the HipA would be inactive. To gain insight
into the conformational and functional effects of the S150A
mutation, we solved the crystal structure of HipA(S150A) to
1.88 A˚ resolution (Table S1; Figures S1A and S1B).
Unexpectedly, the HipA(S150A) structure revealed that resi-
dues 133–155 are no longer present in the protein hydrophobic
core and, similar to the monoclinic pHipA structure, the P loop
motif of HipA(S150A) is largely disordered and points into the
solvent. Thus, the P loop motif of HipA(S150A) adopts the out-
state conformation (Figures S1A and S1B). The underlying
reasonwhy the S150Amutation favors the out state is suggested
by the HipA(D309Q) structure, which shows that in the in state
the Ser150 side chain makes a hydrogen bond to the carbonyl
oxygen of residue Leu64 (Figure S1C). Because there are few
interactions between the loop encompassing Ser150 and the
hydrophobic core, the Ser150-Leu64 hydrogen bond is likely
a key contributor to the stability of the in-state conformation (Fig-
ure 1B). As a result, the loss of this interaction in the S150A
protein would favor the out-state conformation or at least
disfavor the in-state conformation.
HipA Autophosphorylation Prevents ATP Binding
Our structural data show that the P loop motifs of pHipA and
HipA(S150A) take the out-state conformation, which we predict
would lead to the loss of physiologically relevant ATP binding
and hence to an inactive kinase. To test this hypothesis, weCelanalyzed the ability of pHipA and HipA(S150A) to bind adenine
nucleotides. Isothermal titration calorimetry (ITC), employed
previously to analyze ATP binding to HipA(D309Q) (Schumacher
et al., 2009), revealed no interaction between ATP or the nonhy-
drolyzable ATP analog, AMPPNP (adenylylimidodiphosphate),
and pHipA. To ensure that this apparent lack of binding was
not an experimental artifact, we developed an ultraviolet-visible
spectroscopy-based thermal denaturation assay, hypothesizing
that HipA stability would increase as a function of nucleotide
concentration (Waldron and Murphy, 2003; Gue´din et al., 2010)
(Figures 3A–3D). These studies demonstrated a saturable
increase in the thermal stability of HipA(D309Q) upon the addi-
tion of ATP or AMPPNP consistent with high-affinity adenine
nucleotide binding (Kd % 100 mM) (Figure 3A) and with our
previous ITC studies (Schumacher et al., 2009). By contrast,
pHipA showed no increase in its thermal stability even in the
presence of 6.0 mM ATP (Figures 3B and S2A). Congruent with
its preference for the out state, HipA(S150A) showed a small shift
in its thermal stability but only after the addition of more than
2.0 mM ATP (Figure 3C). As expected, ADP also significantly
stabilized dephosphorylated HipA. By contrast, greater than
2.0 mM ADP was required to increase the stability of pHipA
(Figure S2B).
Phosphorylation provides a rapid mechanism for cells to
control the activity of a protein and is typically reversible (John-
son and Lewis, 2001; Taylor and Kornev, 2011). To determine
whether or not dephosphorylation of pHipA restores its ability
to bind ATP and its kinase activity, pHipA was dephosphorylated
by l phosphatase (Barik, 1993). Thermal stability assays demon-
strated that this protein was able to bind AMPPNP with high
affinity (Kd 30 mM) (Figure 3D). Thus, these data demonstrate
that pHipA and HipA(S150A) do not bind ATP or ADP at physio-
logically relevant concentrations and support the idea that the
HipA(S150A) mutant is inactive because it prefers strongly the
out-state conformation.
pHipA Cannot Bind Adenine Nucleotides Productively
Autophosphorylation of an ejected residue that once formed part
of the protein core and active site is unprecedented, but whether
phosphorylation is intramolecular or intermolecular is unclear.
Indeed, the finding from the pHipA structure that the phosphor-
ylated Ser150 residue can dock into the active site with its phos-
phate moiety overlapping the site of the g phosphate of bound
ATP suggested the possibility that autophosphorylation may
be intramolecular. However, an intramolecular phosphorylation
reaction would require ATP binding and g phosphate transfer
to Ser150 concomitant with loop expulsion, a stereochemically
and kinetically unlikely occurrence. Thus, to examine the effect
of P-motif ejection on nucleotide binding, we crystallized pHipA
in the presence of 3 mM ADP, as the ligand-induced thermal
stability data show that pHipA can bind ADP at elevated concen-
trations (Figure S2B). The pHipA-ADP structure was determined
to 2.30 A˚ resolution with Rwork/Rfree values of 23.8%/28.0%. As
a control, the HipA(D309Q)-ADP structure was solved to
2.30 A˚ resolution and refined to Rwork/Rfree values of 22.1%/
26.3% (Table S1).
Strong electron density was observed for the P loop motif and
the entire ADP molecule in the HipA(D309Q)-ADP structurel Reports 2, 518–525, September 27, 2012 ª2012 The Authors 521
Figure 3. Phosphorylation of Residue Ser150 Inhibits ATP Binding and the Catalytic Activity of HipA
(A) Thermal denaturation of HipA(D309Q) as a function of increasing ATP concentration. The normalized absorbance is plotted as a function of temperature. The
concentration range of ATP is given within this panel and in (B)–(D).
(B) Thermal denaturation of pHipA as a function of increasing ATP concentration. See also Figure S2A.
(C) Thermal denaturation of HipA(S150A) as a function of increasing ATP concentration.
(D) Thermal stability of HipA, which has been dephosphorylated by l phosphatase, as a function of increasing AMPPNP concentration. Note the low micromolar
concentration of AMPPNP (between 31 and 140 mM) needed to complete the thermal shift. The thermal stability of HipA and pHipA to bind ADP was assessed
similarly (Figure S2).
(E) Time course of autophosphorylation of l phosphatase-treated wild-type HipA. The ability of HipA(D309Q), HipA(S150A) and pHipA to autophosphorylate were
also tested (Figure S3).(Figure 4A). In addition to van der Waals contacts to the ribose
moiety, the P loop motif of the HipA(D309Q) embraces the
ADP nucleotide phosphates whereby the amide nitrogens of
P loop residues Ala154 andGln155 interact with the ADP b phos-
phate while the Lys157 side chain contacts both the a and
b phosphates (Figure S1C). By sharp contrast, the structure of
the pHipA-ADP complex shows the P loop motif takes the
out state, as observed in other pHipA structures, despite the
presence of nucleotide. More telling, electron density is
observed only for the adenine moiety of the ADP (Figure 4A).
Thus, expulsion of P loop motif residues from the pHipA catalytic
site eliminates key contacts to the ADP ribose and phosphate
groups, while retaining interaction with the adenine moiety
(Figures 4A and 4B). As noted above, the transfer of the g phos-
phate of ATP to the substrate by serine/threonine protein kinases
demands not only tight binding of ATP but also the precise
alignment of the g phosphate and substrate hydroxyl group.
The lack of density for the ribose and phosphate moieties of522 Cell Reports 2, 518–525, September 27, 2012 ª2012 The AuthorADP in the pHipA-ADP structure provides visible evidence to
support the idea that the kinase P loopmotif is required to anchor
the phosphate moieties in place for efficient catalysis. Without
these stabilizing interactions the phosphates are too flexible
and indicate intramolecular autophosphorylation would be
highly improbable. Thus, the structural data show that pHipA is
unable to bind adenine nucleotides productively and suggests
that HipA Ser150 autophosphorylation is an intermolecular
event.
HipA Autophosphorylation Is Intermolecular
To address unambiguously whether the phosphorylation of
HipA is an intra- or intermolecular event, we examined the
ability of l phosphatase-dephosphorylated HipA to phos-
phorylate a peptide corresponding to HipA residues 143–157
(EENDFRISVAGAQEK), which includes Ser150. Mass spectrom-
etry was carried out and revealed that the peptide was indeed
phosphorylated by HipA (Figure 4C). This demonstrates thats
Figure 4. HipA Phosphorylation Is Intermolecular: A Model for MDT Development
(A) Fo-Fc electron density maps (blue mesh, contoured at 4s) of the HipA(D309Q)-ADP (left) and pHipA-ADP (right) structures calculated before inclusion of
nucleotide. Weak electron density is observed only for the adenine moiety in the pHipA-ADP complex, whereas density for the full ADP molecule is seen in the
HipA(D309Q)-ADP complex.
(B) View into the catalytic pocket of HipA after superimposition of the HipA(D309Q)-ADP and pHipA-ADP structures. The P loop motif of the HipA(D309Q)-ADP
structure is shown in green and that of the pHipA-ADP structure is shown in red. In the pHipA-ADP structure the P loop is ejected, thereby destroying nearly the
entire nucleotide binding pocket, while in the HipA(D309Q)-ADP structure the P loop motif is folded into the protein core and forms the canonical P loop-turn
structure that embraces the ADP phosphates. The overlaid HipA proteins are shown as gray surface representations. The only other case of P-loop kinase
phosphorylation involves phosphorylation of an exposed tyrosine of CDK2 (Welburn et al., 2007), which does not require P-loop ejection or conformational
changes (see Figure S4).
(C) Mass spectrometry analysis of an in vitro phosphorylation assay examining the ability of dephosphorylated HipA to phosphorylate the HipA peptide,
EENDFRISVAGAQEK, which encompassesHipA residue Ser150. The top frame is the control (no HipA added to the peptide) and the bottom frame is the included
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autophosphorylation can take place intermolecularly. However,
to test this in vivo we coexpressed HipA and kinase-dead, hex-
ahistidine-tagged HipA(D309Q) and performed mass spectrom-
etry on the purified D309Q protein. Because HipA(D309Q) shows
no kinase activity, phosphorylation of its Ser150 residue would
provide clear evidence for in vivo intermolecular phosphorylation
by the coexpressed wt HipA protein. This analysis revealed
that HipA(D309Q) was, in fact, phosphorylated. Thus, both
in vitro and in vivo studies support that HipA autophosphoryla-
tion is intermolecular. This finding is consistent with the fact
that the P loop motif of pHipA can no longer bind ATP due to
its restructuring and ejection from the protein core and that
HipA phosphorylation must be carried out by a second HipA
with an in-state conformation P loop. Thus, our combined data
show that the pHipA is inactive. Having deduced that HipA phos-
phorylation is intermolecular, we utilized our kinase assay to
assess phosphorylation of the kinase-dead HipA(D309Q) by
the HipA(S150A) and pHipA proteins. Strikingly, HipA(S150A)
showed no kinase activity even when using ATP concentrations
as high as 3 mM (Figure S3A). By contrast, the pHipA sample
showed a small amount of autophosphorylation. However, this
phosphorylation is the direct result of the incomplete modifica-
tion of the HipA protein. Indeed, mass spectrometry analysis of
pure pHipA reveals 25% of the protein is not phosphorylated
(Figure S3B). In accord, increasing the percentage of phosphor-
ylated HipA diminishes the observed but artifactual kinase
activity of pHipA.
A Mechanism for Kinase Inactivation Plays a Central
Role in Multidrug Tolerance
The data show that HipA utilizes a newly described mechanism
of kinase autoinhibition involving P loop motif ejection followed
by intermolecular autophosphorylation. By contrast, regulatory
phosphorylation of essentially all protein kinases involves modi-
fication of activation region/loop residues. CDK2, which is phos-
phorylated by a Wee1/Mik1 kinase on P loop residue Tyr15, is
the only other example of P loop residue phosphorylation
(Welburn et al., 2007). However, because Tyr15 is located on
the exposed P loop tip and CDK2 possesses a much smaller
N-domain than HipA, Tyr15 phosphorylation requires no confor-
mational change and the resultant CDK2-pTyr15 structure is
essentially identical to the nonphosphorylated protein (Figures
S4A and S4B). Moreover, CDK2-pTyr15 can still bind ATP and
phosphorylation appears to inhibit function simply by blocking
the protein substrate-binding site (Welburn et al., 2007). By sharp
contrast, residue Ser150 of HipA is buried in the protein core
and a dramatic structural change is required to effect its
phosphorylation.
Our combined data suggest a HipA-mediated persistence
cycle in which HipA is initially inhibited by binding to HipB,dephosphorylated wtHipA. The presence of the phosphorylated peptide product
denoted by +P in red.
(D) Model for HipA-mediated MDT. HipA normally is inhibited via its interaction w
the intrinsically labile HipB protein is proteolysed to allow HipA release, HipA will p
by the yellow cell) (Schumacher et al., 2009). To emerge from dormancy, HipA m
phorylation of its P loop motif. This provides cells time to ‘‘reset’’ and re-enter
treatment and remained quiescent until drug removal, the emergence of cells fro
524 Cell Reports 2, 518–525, September 27, 2012 ª2012 The Authorthereby sequestering HipA from substrates and locking this
enzyme in an inactive conformation (Schumacher et al., 2009).
Indeed, coexpression of HipB and HipA reveals no HipA-auto-
phosphorylation (Evdokimov et al., 2009). Upon release from
HipB, HipA phosphorylates target proteins thereby inducing
persistence. Subsequent autophosphorylation is the crucial
initial event that is necessary to allow persister cells to revert to
a growth phenotype as this modification squelches the HipA
kinase activity (Figure 4D).Whether pHipA is degraded ultimately
is currently unknown and a difficult issue to address given that
only one in a million cells become a persister and each persister
cell contains only a few molecules of HipA. This dearth also
makes tracking how the conformations of a few molecules of
HipA contribute to the frequency and duration of persistence
currently intractable. Logically pHipA degradation and HipB
binding to newly synthesized HipA would be the most effective
subsequent steps to restore the growth phenotype. On the other
hand, control of the length of persistence could involve a robust
mechanism of dephosphorylation of pHipA. However, our efforts
to identify a HipA-specific phosphatase have been unsuccessful
thus far. Regardless, the conformational dynamics of the P loop
motif of HipA dramatically and directly affect persistence as any
event, which favors the out state, including phosphorylation of
Ser150 or loss of an in-state stabilizing interaction as observed
in HipA(S150A), results in the loss of persistence (Correia et al.,
2006).
Finally, a simple bioinformatic analysis of the currently avail-
able bacterial genomes reveals that the hipBA system is highly
conserved among Gram-negative bacteria with HipA proteins
showing sequence identities ranging from 45% to 95%. Strik-
ingly, Ser150 is as highly conserved as the catalytic residues of
these putative HipA proteins. These findings suggest that the
hipBA system is an important MDT/persister module in many
Gram-negative organisms and further, that HipA autophosphor-
ylation, which provides a self-inactivation mechanism, plays
a fundamental role in MDT development.
EXPERIMENTAL PROCEDURES
HipA proteins were purified via Ni2+-NTA chromatography. Purified wt HipA is
typically 65%–90% phosphorylated on residue Ser150 (Correia et al., 2006
and our results). Dephosphorylated wt HipA was prepared by treating pHipA
with l phosphatase. pHipA, HipA(S150A), pHipA-ADP, and HipA(D309Q)-
ADP structures were solved by molecular replacement. Phosphorylation of
the HipA 15-mer peptide by dephosphorylated HipA or pHipA was analyzed
by mass spectrometry. For a full description of all the experimental methods,
see Extended Experimental Procedures.
ACCESSION NUMBERS
Coordinates and structure factor files for HipA(S150A), pHipA P21, pHipA
P3121, HipA(D309Q-ADP), and pHipA-ADP have been deposited in the Protein(+ 80 Da) was clearly evident in the presence of dephosphorylated HipA and is
ith HipB, which binds four operator sites in the hipBA promoter. If enough of
hosphorylate EF-Tu and potentially other targets causing cell stasis (indicated
ust be inactivated. This is mediated by the unusual intermolecular autophos-
the growth phase. If the persister cells achieved dormancy during antibiotic
m the dormant stage leads to reinfection or multidrug tolerance.
s
Data Bank under the accession codes 3TPB, 3TPD, 3TPE, 3TPT, and 3TPV,
respectively.
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